Newsroom-Katalog
| Zeit | Boehringer Ingelheim: Meldungen vom 16.11.2009 |
|---|---|
| 14:11 | Flibanserin Demonstrates Efficacy and Tolerability in Pivotal Phase III Trials in Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD) |
| Zeit | Boehringer Ingelheim: Meldungen vom 16.11.2009 |
|---|---|
| 14:11 | Flibanserin Demonstrates Efficacy and Tolerability in Pivotal Phase III Trials in Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD) |